Author:
Vyas Vivek K.,Qureshi Gulamnizami,Oza Drashti,Patel Hardik,Parmar Krupali,Patel Palak,Ghate Manjunath D.
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference15 articles.
1. The dihydroorotate dehydrogenases: past and present;Reis;Arch Biochem Biophys,2017
2. Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) Inhibitors;Vyas;Mini-Reviews Med Chem,2011
3. Pyrimidine pathways in health and disease;Löffler;Trends Mol Med,2005
4. Correction: a DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage (Nature Communications (2018) DOI: 10.1038/s41467-018-03441-3);Ladds;Nat Commun,2018
5. Mechanism of action of the novel anticancer agent 6-Fluoro-2-(2’-fluoro-1,1’-biphenyl-4-yl)-3-methyl-4-quinolinecarboxylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis;Chen;Cancer Res,1986
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献